CSPC Pharmaceutical Group (HKG:1093) plans to further buy back shares on the market for up to HK$5 billion including the buyback plan of HK$1 billion approved earlier.

The company has already utilized HK$773 million of the HK$1 billion buyback plan to repurchase 163,860,000 shares as of Thursday, a same-day filing with the Hong Kong Exchange said.

The bought-back shares will be cancelled, the disclosure said.

CSPC Pharmaceutical Group had already repurchased shares for HK$387 million in the first half of this year.

Shares of the company rose 1% at close of Thursday trade.

Price (HKD): $4.69, Change: $+0.040, Percent Change: +0.86%